US20010004708A1 - Intraocular ring - Google Patents

Intraocular ring Download PDF

Info

Publication number
US20010004708A1
US20010004708A1 US09/227,971 US22797199A US2001004708A1 US 20010004708 A1 US20010004708 A1 US 20010004708A1 US 22797199 A US22797199 A US 22797199A US 2001004708 A1 US2001004708 A1 US 2001004708A1
Authority
US
United States
Prior art keywords
ring
intraocular
capsule
intraocular ring
cut
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US09/227,971
Other versions
US6428572B2 (en
Inventor
Hidenobu Nagai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Menicon Co Ltd
Original Assignee
Menicon Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menicon Co Ltd filed Critical Menicon Co Ltd
Assigned to MENICON CO., LTD. reassignment MENICON CO., LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NAGAI, HIDENOBU
Publication of US20010004708A1 publication Critical patent/US20010004708A1/en
Application granted granted Critical
Publication of US6428572B2 publication Critical patent/US6428572B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2/1694Capsular bag spreaders therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/147Implants to be inserted in the stroma for refractive correction, e.g. ring-like implants
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S623/00Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
    • Y10S623/902Method of implanting
    • Y10S623/905Eye
    • Y10S623/906Corneal

Definitions

  • the present invention relates to an intraocular ring. More particularly, it relates to an intraocular ring to be worn inside of the equatorial area of a lenticular capsule (hereinafter called capsule) undergoing extracapsular cataract extraction (including phacoemulsification aspiration) for treatment of cataract in order to hold the capsule in a circular form.
  • capsule lenticular capsule
  • extracapsular cataract extraction including phacoemulsification aspiration
  • Intraocular rings for retaining the shape of the capsule after extracapsular cataract extraction are roughly classified into the open ring as disclosed in Japanese Examined Patent Publication No. 51302/1993 (see FIG. 33 and FIG. 34), and the closed ring as disclosed in Japanese Examined Patent Publication No. 9582/1994 or Japanese Unexamined Patent Publication No. 364840/1992 (see FIG. 35, FIG. 36, and FIG. 37).
  • European Patent Publication No. 0478929A1 discloses an intraocular ring (see FIG. 31 and FIG. 32) having a lock mechanism (locking achieved by inserting and engaging) 102 forming divided and plural step parts.
  • this intraocular ring 100 after adjusting the diameter of the intraocular ring 100 by the lock mechanism 102 , the intraocular ring 100 must be inserted into the capsule, and it cannot be inserted into the capsule in a divided state as in the above-mentioned open ring and the defects of the closed ring ( 2 ) are not solved.
  • an intraocular ring which is an open ring type intraocular ring when inserting, the intraocular ring capable of being inserted from small incision and, after being inserted into the capsule, is capable of obtaining a same compressive load as in the closed ring by engaging the engaging mechanisms having mutually complementary male and female structures provided at the ends of the intraocular ring.
  • the intraocular ring in one embodiment of the present invention is an intraocular ring made of an elastic material, and contacting with entire inner circumference of an equatorial area of a capsule after being inserted in the capsule, in which engaging mechanisms are provided at both ends, in a partially cut-off state of the intraocular ring, and a continuous ring shape without cut section is formed by engagement of the engaging mechanisms.
  • the intraocular ring engaging mechanisms include mutually complementary male and female structures.
  • the intraocular ring in another embodiment of the present invention is a partially cut-off intraocular ring made of an elastic material, and contacting with entire inner circumference of an equatorial area of a capsule after being inserted in the capsule, in which a continuous shape is formed when the intraocular ring is inserted in the capsule as the both ends of the cut-off intraocular ring contact with each other.
  • the both ends of the intraocular ring are formed in a taper.
  • the intraocular ring in still another embodiment of the present invention is an intraocular ring comprising two or three or more parts, made of an elastic material, and said intraocular ring contacting with entire inner circumference of an equatorial area of the capsule after being inserted in the capsule, in which the two or three or more parts individually have engaging mechanisms provided at both ends so that arbitrary adjacent parts may be engaged with each other in a male-female structure, and a continuous ring shape without cut section is formed when the two or three or more parts are mutually engaged with each other.
  • a predetermined compressive load is applied in the engaged state of the cut sections of the ring.
  • the compressive load is about 250 mgf or more.
  • At least one end of both ends of the intraocular ring is provided with a flange, since circumferential or axial deviation of one end of the intraocular ring relative to the other end thereof is prevented.
  • the intraocular ring as set forth in claims 1 to 10 of the invention, it is an intraocular ring of open ring shape when inserting, and it can be inserted from a small incision, and after inserting into the capsule, a compressive load nearly same as in the closed ring is obtained by engaging the engaging mechanisms having mutually complementary male and female structures provided at the ends of the intraocular ring.
  • the intraocular ring (hereinafter called the ring) of the invention is described in detail below.
  • FIG. 1( a ) is a plan view showing one example of an embodiment of ring of the present invention
  • FIG. 1( b ) is a sectional view showing an engaged state of the ring of FIG. 1( a );
  • FIG. 2 is a plan view showing another example of the ring of FIGS. 1 ( a ) and 1 ( b );
  • FIG. 3 is a plan view showing still another example of the ring of FIGS. 1 ( a ) and 1 ( b );
  • FIG. 4 is a plan view showing an engaged state of the ring of FIG. 3;
  • FIG. 5 is a plan view showing another embodiment of a ring of the present invention in which the ring is composed of two parts;
  • FIG. 6 is a plan view showing a state of the ring of FIG. 5 in which the two part is swingably engaged with each other;
  • FIG. 7 is a plan view showing a state of the ring of FIG. 5 serving as an open ring;
  • FIGS. 8 ( a ) to 8 ( e ) show partial plan views, each showing an example of an engaged state of the ring of the present invention
  • FIGS. 9 ( a ) to 9 ( d ) are partial plan views each showing another example of an engaged state of the ring of FIGS. 8 ( a ) and 8 ( e );
  • FIGS. 10 ( a ) to 10 ( e ) are partial plan views each showing still another example of an engaged state of the ring of FIGS. 8 ( a ) to 8 ( e );
  • FIGS. 11 ( a ) to 11 ( d ) are partial plan views each showing yet another example of an engaged state of the ring of FIGS. 8 ( a ) to 8 ( e );
  • FIG. 12( a ) to 12 ( e ) are partial plan views each showing yet another example of an engaged state of the ring of FIGS. 8 ( a ) to 8 ( e );
  • FIGS. 13 ( a ) to 13 ( d ) are partial plan view each showing yet another example of an engaged state of the ring of FIGS. 8 ( a ) to 8 ( e );
  • FIGS. 14 ( a ) to 14 ( e ) are partial plan views each showing yet another example of an engaged state of the ring of FIGS. 8 ( a ) to 8 ( e );
  • FIGS. 15 ( a ) to 15 ( d ) are partial plan views each showing yet another example of an engaged state of the ring of FIGS. 8 ( a ) to 8 ( e );
  • FIGS. 16 ( a ) to 16 ( e ) are partial side views each showing one example of an engaged state of the ring of FIGS. 8 ( a ) to 8 ( e );
  • FIGS. 17 ( a ) to 17 ( d ) are partial side views each showing another example of an engaged state of the ring of FIGS. 16 ( a ) to 16 ( e );
  • FIGS. 18 ( a ) to 18 ( e ) are partial side views each showing still another example of an engaged state of the ring of FIGS. 16 ( a ) to 16 ( e );
  • FIGS. 19 ( a ) to 19 ( d ) are partial side views each showing yet another example of an engaged state of the ring of FIGS. 16 ( a ) to 16 ( e );
  • FIGS. 20 ( a ) to 20 ( e ) are partial side views each showing yet another example of an engaged state of the ring of FIGS. 16 ( a ) to 16 ( e );
  • FIGS. 21 ( a ) to 21 ( d ) are partial side views each showing yet another example of an engaged state of the ring of FIGS. 16 ( a ) to 16 ( e );
  • FIGS. 22 ( a ) to 22 ( e ) are partial side views each showing yet another example of an engaged state of the ring of FIGS. 16 ( a ) to 16 ( e );
  • FIGS. 23 ( a ) to 23 ( d ) are partial side views each showing yet another example of an engaged state of the ring of FIGS. 16 ( a ) to 16 ( d );
  • FIG. 24 is a perspective view showing an example of still another embodiment of a ring of the present invention.
  • FIG. 25 is a perspective view showing another example of the ring of FIG. 24;
  • FIG. 26 is a perspective view showing still another example of the ring of FIG. 24;
  • FIGS. 27 ( a ) to 27 ( e ) are partial side views each showing yet another example of the ring of FIGS. 24 to 26 ;
  • FIGS. 28 ( a ) to 28 ( d ) are partial side views showing yet another example of the ring of FIGS. 24 to 26 ;
  • FIGS. 29 ( a ) to 29 ( c ) are partial side views each showing yet another example of the ring of FIGS. 24 to 26 ;
  • FIGS. 30 ( a ) to 30 ( c ) are partial side views each showing yet another example of the ring of FIGS. 24 to 26 ;
  • FIG. 31 is a plan view showing one example of conventional ring
  • FIG. 32 is a partially enlarged view of the ring of FIG. 31;
  • FIG. 33 is a plan view showing another example of conventional ring
  • FIG. 34 is a plan view showing a state of the ring of FIG. 33, which is inserted into a capsule;
  • FIG. 35 is a perspective view showing still another example of the ring of FIG. 24;
  • FIG. 36 is an explanatory view showing a method for inserting a conventional ring into a capsule.
  • FIG. 37 is an explanatory view showing a method for inserting a conventional ring into a capsule.
  • a ring 1 of this embodiment is composed of a biocompatible material such as poly (methyl methacrylate) (PMMA), polypropylene (PP), hydrogel, fibronectin, polysulfone, chondroitin sulfate, a compound of hyaluronic acid, or similar compound, a biopolymer such as hydroxyethyl methacrylate, N-vinyl pyrrolidone, vinyl alcohol, or collagen, an elastomer such as silicone rubber, acrylic rubber, or their mixture or copolymer, a material such as polyethylene, vinyl chloride, poly (vinylidene fluoride), polyurethane, ethylene-vinyl acetate copolymer, siloxanyl styrene, similar material, and also a polymer such as polyurea, polyether, polyester, or copolysiloxane, a polymer such as polyacrylate or poly
  • the ring 1 is partially cut off, that is, a so-called open ring, in which a male part M having a protrusion 5 is formed at one end of the cut section, and a female part F having a recess 10 complementary to the protrusion 5 is formed at other end.
  • the male part M and female part F compose an engaging mechanism 2 .
  • the ring 1 of this embodiment is an intraocular ring in a constitution as shown in any one of partial plan views of FIG. 8 ( a ), FIG. 9 ( c ) and FIG. 9( d ), and a side view in FIG. 17( d ), and when inserted into the capsule, the both ends of the cut ring are joined to form a continuous shape.
  • the ring 1 of the embodiment as shown in FIG. 9( b ) and FIG. 9( c ) and FIG. 17( c ), has tapers T 1 , T 2 formed at both ends of the ring 1 .
  • the material of the ring 1 of this embodiment is same as that of the ring of embodiment 1.
  • a compressive load of about 250 mgf or more is obtained.
  • the ring 1 of this embodiment is composed of part 1 a and part 1 b (see FIG. 5).
  • a first protrusion 5 a and a first recess 10 a positioned at the root of the first protrusion 5 a are formed at one end of the part 1 a , while a second protrusion 5 b is formed at other end.
  • a third protrusion 5 c to be fitted into the first recess 10 a , and a second recess 10 b positioned at the root of the third protrusion 5 c are formed, while a third recess 10 c to be fitted with the second protrusion 5 b is formed at other end.
  • the ring 1 of the embodiment is inserted into the capsule (see FIG. 6), first in a state of fitting the first protrusion 5 a into the second recess 10 b by means of jig such as forcept.
  • jig such as forcept.
  • a tension is applied to the ring 1 .
  • the second protrusion 5 b is fitted into the third recess 10 c .
  • the material of the ring 1 of this embodiment is same as that of the ring of embodiment 1.
  • the ring of the invention is a so-called open ring with one or two or more cut sections.
  • the engaging or joining mechanism of cut sections is explained by referring to the drawings, but it is not limited to the illustrated engaging and joining mechanisms.
  • ocular hypotensor such as distigmine bromide, carteolol chloride or timolol maleate
  • cataract remedy such as pyrenoxin or glutathione
  • ocular infection remedy such as aciclovir, idoxuridine, oxytetracycline hydrochloride, ofloxacin, sulbenicillin sodium, cefmenoxime hydrochloride, tobramycin, micronomycin hydrosulfate or pimaricin
  • anti-inflammatory agents such as dexamethasone sodium phosphate, fluorometholone, metamethasone sodium phosphate, indomethacin or pranoprofen
  • antifungal agent such as griseofulvin
  • antibacterial agent such as gentamycin sulfate
  • antiviral agent such as vidarabine
  • diagnostic agent such as fluorescein sodium
  • the ring 1 of EMBODIMENT 5 is characterized in that a flange portion FL is located in a position where both ends of the ring 1 are abutted to each other.
  • the shape of the flange FL not only the shape shown in FIGS. to 26 , but also the shape shown in FIGS. 27 ( a ) to 27 ( e ), 28 ( a ) to 28 ( d ), 29 ( a ) to 29 ( c ) and 30 ( a ) to 30 ( c ) can be employed.
  • the present invention since it is an intraocular ring of open ring shape when inserting, it can be inserted from a small incision, and after being inserted into the capsule, by engaging the engaging mechanisms having mutually complementary male and female structures provided at ends of the intraocular ring, the intraocular ring having a nearly same compressive load as in closed ring is obtained.

Abstract

It is an intraocular ring of open ring shape when inserting, so that it can be inserted from a small incision, and after being inserted into the capsule, by engaging the engaging mechanisms having mutually complementary male and female structures provided at ends of the intraocular ring, the intraocular ring having a nearly same compressive load as in closed ring is presented. Being made of an elastic material, it is an intraocular ring composed to contact with the entire inner circumference of the equatorial area in the capsule when inserted into the lenticular capsule, and engaging mechanisms are disposed at both ends in a partially cut-off state of the intraocular ring, and by engagement of the engaging mechanisms, a continuous ring shape without cut section is formed.

Description

    BACKGROUND OF THE INVENTION
  • The present invention relates to an intraocular ring. More particularly, it relates to an intraocular ring to be worn inside of the equatorial area of a lenticular capsule (hereinafter called capsule) undergoing extracapsular cataract extraction (including phacoemulsification aspiration) for treatment of cataract in order to hold the capsule in a circular form. [0001]
  • Intraocular rings for retaining the shape of the capsule after extracapsular cataract extraction (including phacoemulsification aspiration) are roughly classified into the open ring as disclosed in Japanese Examined Patent Publication No. 51302/1993 (see FIG. 33 and FIG. 34), and the closed ring as disclosed in Japanese Examined Patent Publication No. 9582/1994 or Japanese Unexamined Patent Publication No. 364840/1992 (see FIG. 35, FIG. 36, and FIG. 37). [0002]
  • (1) It is an advantage of the open ring that the intraocular ring can be inserted easily into the capsule, but since the cut position of the ring is simultaneously movable, its demerit is that it is poor in the shape retaining property of the capsule following extracapsular cataract extraction (including phacoemulsification aspiration). [0003]
  • (2) In the case of a closed ring, after extracapsular cataract extraction (including phacoemulsification aspiration), as shown in FIG. 36 and FIG. 37, the capsule is filled up sufficiently with a viscous fluid, and an [0004] intraocular ring 100 is picked by forceps P (or injector (not shown) for soft lens) and deflected in a nearly rectangular shape, and the intraocular ring 100 is gradually inserted into the capsule through a cut S and a cut H. When inserted in the capsule, by the own elasticity of the intraocular ring 100, it restores the original annular shape and contacts with the whole circumference of the equatorial area of the capsule. Therefore, the closed ring is excellent in the shape retaining performance of the capsule after removal of the lens.
  • However, it requires a highly advanced skill in the operation of picking the [0005] intraocular ring 100 by the forceps P to deflect nearly in a rectangular form and inserting the intraocular ring 100 gradually into the capsule through the cut S and cut H, and it is difficult to insert the intraocular ring into the capsule. As compared with the open ring, yet, the cuts are larger, and troubles may be caused after operation (such as postoperative astigmatism).
  • On the other hand, European Patent Publication No. 0478929A1 discloses an intraocular ring (see FIG. 31 and FIG. 32) having a lock mechanism (locking achieved by inserting and engaging) [0006] 102 forming divided and plural step parts. In the case of this intraocular ring 100, after adjusting the diameter of the intraocular ring 100 by the lock mechanism 102, the intraocular ring 100 must be inserted into the capsule, and it cannot be inserted into the capsule in a divided state as in the above-mentioned open ring and the defects of the closed ring (2) are not solved.
  • Moreover, in the case of the intraocular ring disclosed in European Patent Publication No. 0478929A1, since the shrinking direction of the capsule and the ring size changing direction are identical, if a strong shrinkage occurs in the capsule, the ring size is also deformed. As a result, if part of the ring is adhered to the tissues, the original circular shape cannot be maintained but is deformed, which may lead to decentration of the intraocular lens. [0007]
  • It is hence an object of the invention to solve the problems of the prior arts, and present an intraocular ring, which is an open ring type intraocular ring when inserting, the intraocular ring capable of being inserted from small incision and, after being inserted into the capsule, is capable of obtaining a same compressive load as in the closed ring by engaging the engaging mechanisms having mutually complementary male and female structures provided at the ends of the intraocular ring. [0008]
  • SUMMARY OF THE INVENTION
  • The intraocular ring in one embodiment of the present invention is an intraocular ring made of an elastic material, and contacting with entire inner circumference of an equatorial area of a capsule after being inserted in the capsule, in which engaging mechanisms are provided at both ends, in a partially cut-off state of the intraocular ring, and a continuous ring shape without cut section is formed by engagement of the engaging mechanisms. [0009]
  • Preferably, the intraocular ring engaging mechanisms include mutually complementary male and female structures. [0010]
  • The intraocular ring in another embodiment of the present invention is a partially cut-off intraocular ring made of an elastic material, and contacting with entire inner circumference of an equatorial area of a capsule after being inserted in the capsule, in which a continuous shape is formed when the intraocular ring is inserted in the capsule as the both ends of the cut-off intraocular ring contact with each other. [0011]
  • Preferably, the both ends of the intraocular ring are formed in a taper. [0012]
  • The intraocular ring in still another embodiment of the present invention is an intraocular ring comprising two or three or more parts, made of an elastic material, and said intraocular ring contacting with entire inner circumference of an equatorial area of the capsule after being inserted in the capsule, in which the two or three or more parts individually have engaging mechanisms provided at both ends so that arbitrary adjacent parts may be engaged with each other in a male-female structure, and a continuous ring shape without cut section is formed when the two or three or more parts are mutually engaged with each other. [0013]
  • Preferably, a predetermined compressive load is applied in the engaged state of the cut sections of the ring. [0014]
  • Preferably, the compressive load is about 250 mgf or more. [0015]
  • Preferably, at least one end of both ends of the intraocular ring is provided with a flange, since circumferential or axial deviation of one end of the intraocular ring relative to the other end thereof is prevented. [0016]
  • According to the intraocular ring as set forth in [0017] claims 1 to 10 of the invention, it is an intraocular ring of open ring shape when inserting, and it can be inserted from a small incision, and after inserting into the capsule, a compressive load nearly same as in the closed ring is obtained by engaging the engaging mechanisms having mutually complementary male and female structures provided at the ends of the intraocular ring.
  • Referring now to the accompanying drawings, the intraocular ring (hereinafter called the ring) of the invention is described in detail below. [0018]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1([0019] a) is a plan view showing one example of an embodiment of ring of the present invention, and FIG. 1(b) is a sectional view showing an engaged state of the ring of FIG. 1(a);
  • FIG. 2 is a plan view showing another example of the ring of FIGS. [0020] 1(a) and 1(b);
  • FIG. 3 is a plan view showing still another example of the ring of FIGS. [0021] 1(a) and 1(b);
  • FIG. 4 is a plan view showing an engaged state of the ring of FIG. 3; [0022]
  • FIG. 5 is a plan view showing another embodiment of a ring of the present invention in which the ring is composed of two parts; [0023]
  • FIG. 6 is a plan view showing a state of the ring of FIG. 5 in which the two part is swingably engaged with each other; [0024]
  • FIG. 7 is a plan view showing a state of the ring of FIG. 5 serving as an open ring; [0025]
  • FIGS. [0026] 8(a) to 8(e) show partial plan views, each showing an example of an engaged state of the ring of the present invention;
  • FIGS. [0027] 9(a) to 9(d) are partial plan views each showing another example of an engaged state of the ring of FIGS. 8(a) and 8(e);
  • FIGS. [0028] 10(a) to 10(e) are partial plan views each showing still another example of an engaged state of the ring of FIGS. 8(a) to 8(e);
  • FIGS. [0029] 11(a) to 11(d) are partial plan views each showing yet another example of an engaged state of the ring of FIGS. 8(a) to 8(e);
  • FIG. 12([0030] a) to 12(e) are partial plan views each showing yet another example of an engaged state of the ring of FIGS. 8(a) to 8(e);
  • FIGS. [0031] 13(a) to 13(d) are partial plan view each showing yet another example of an engaged state of the ring of FIGS. 8(a) to 8(e);
  • FIGS. [0032] 14(a) to 14(e) are partial plan views each showing yet another example of an engaged state of the ring of FIGS. 8(a) to 8(e);
  • FIGS. [0033] 15(a) to 15(d) are partial plan views each showing yet another example of an engaged state of the ring of FIGS. 8(a) to 8(e);
  • FIGS. [0034] 16(a) to 16(e) are partial side views each showing one example of an engaged state of the ring of FIGS. 8(a) to 8(e);
  • FIGS. [0035] 17(a) to 17(d) are partial side views each showing another example of an engaged state of the ring of FIGS. 16(a) to 16(e);
  • FIGS. [0036] 18(a) to 18(e) are partial side views each showing still another example of an engaged state of the ring of FIGS. 16(a) to 16(e);
  • FIGS. [0037] 19(a) to 19(d) are partial side views each showing yet another example of an engaged state of the ring of FIGS. 16(a) to 16(e);
  • FIGS. [0038] 20(a) to 20(e) are partial side views each showing yet another example of an engaged state of the ring of FIGS. 16(a) to 16(e);
  • FIGS. [0039] 21(a) to 21(d) are partial side views each showing yet another example of an engaged state of the ring of FIGS. 16(a) to 16(e);
  • FIGS. [0040] 22(a) to 22(e) are partial side views each showing yet another example of an engaged state of the ring of FIGS. 16(a) to 16(e);
  • FIGS. [0041] 23(a) to 23(d) are partial side views each showing yet another example of an engaged state of the ring of FIGS. 16(a) to 16(d);
  • FIG. 24 is a perspective view showing an example of still another embodiment of a ring of the present invention; [0042]
  • FIG. 25 is a perspective view showing another example of the ring of FIG. 24; [0043]
  • FIG. 26 is a perspective view showing still another example of the ring of FIG. 24; [0044]
  • FIGS. [0045] 27(a) to 27(e) are partial side views each showing yet another example of the ring of FIGS. 24 to 26;
  • FIGS. [0046] 28(a) to 28(d) are partial side views showing yet another example of the ring of FIGS. 24 to 26;
  • FIGS. [0047] 29(a) to 29(c) are partial side views each showing yet another example of the ring of FIGS. 24 to 26;
  • FIGS. [0048] 30(a) to 30(c) are partial side views each showing yet another example of the ring of FIGS. 24 to 26;
  • FIG. 31 is a plan view showing one example of conventional ring; [0049]
  • FIG. 32 is a partially enlarged view of the ring of FIG. 31; [0050]
  • FIG. 33 is a plan view showing another example of conventional ring; [0051]
  • FIG. 34 is a plan view showing a state of the ring of FIG. 33, which is inserted into a capsule; [0052]
  • FIG. 35 is a perspective view showing still another example of the ring of FIG. 24; [0053]
  • FIG. 36 is an explanatory view showing a method for inserting a conventional ring into a capsule; and [0054]
  • FIG. 37 is an explanatory view showing a method for inserting a conventional ring into a capsule. [0055]
  • EMBODIMENT 1
  • Referring to FIG. 1([0056] a) and FIG. 1(b), a ring 1 of this embodiment is composed of a biocompatible material such as poly (methyl methacrylate) (PMMA), polypropylene (PP), hydrogel, fibronectin, polysulfone, chondroitin sulfate, a compound of hyaluronic acid, or similar compound, a biopolymer such as hydroxyethyl methacrylate, N-vinyl pyrrolidone, vinyl alcohol, or collagen, an elastomer such as silicone rubber, acrylic rubber, or their mixture or copolymer, a material such as polyethylene, vinyl chloride, poly (vinylidene fluoride), polyurethane, ethylene-vinyl acetate copolymer, siloxanyl styrene, similar material, and also a polymer such as polyurea, polyether, polyester, or copolysiloxane, a polymer such as polyacrylate or polymethacrylate, methyl methacrylate, styrene, methyl styrene, vinyl pyridine, similar copolymer, a copolymer such as N-alkyl, N,N-dialkyl acrylamide, or methacrylamide, or other shape memory material.
  • The [0057] ring 1 is partially cut off, that is, a so-called open ring, in which a male part M having a protrusion 5 is formed at one end of the cut section, and a female part F having a recess 10 complementary to the protrusion 5 is formed at other end. The male part M and female part F compose an engaging mechanism 2.
  • As the male part M and female part F engage with each other, a continuous ring form without cut section is formed. [0058]
  • Further, in this embodiment, since the supporting [0059] protrusion 5 is formed in the male part M, after engagement of the male part M and female part F, this supporting protrusion 5 contacts with the root of the female part F. As a result, a uniform tension (compressive load) is applied to the entire ring 1. In the case of the ring of the embodiment, after engagement of the male part M and female part F, when the ring diameter is contracted by 2 mm, a compressive load of about 250 mgf or more is obtained.
  • EMBODIMENT 2
  • The [0060] ring 1 of this embodiment is an intraocular ring in a constitution as shown in any one of partial plan views of FIG. 8 (a), FIG. 9 (c) and FIG. 9(d), and a side view in FIG. 17(d), and when inserted into the capsule, the both ends of the cut ring are joined to form a continuous shape.
  • The material of the [0061] ring 1 of this embodiment is same as that of the ring of embodiment 1.
  • In the case of the ring of this embodiment, too, after joining the both ends of the cut ring, when the ring diameter is contracted by 2 mm, a compressive load of about 250 mgf or more is obtained. [0062]
  • EMBODIMENT 3
  • The [0063] ring 1 of the embodiment, as shown in FIG. 9(b) and FIG. 9(c) and FIG. 17(c), has tapers T1, T2 formed at both ends of the ring 1. In this constitution, it is preferred as deviation of abutting position of the tapers T1 and T2 is prevented. The material of the ring 1 of this embodiment is same as that of the ring of embodiment 1. Also the case of the ring of this embodiment, after joining the tapers T1 and T2, when the ring diameter is contracted by 2 mm, a compressive load of about 250 mgf or more is obtained.
  • EMBODIMENT 4
  • The [0064] ring 1 of this embodiment is composed of part 1 a and part 1 b (see FIG. 5).
  • In the [0065] part 1 a and part 1 b, in order that arbitrary adjacent parts may be engaged with each other in a male-female structure, a first protrusion 5 a and a first recess 10 a positioned at the root of the first protrusion 5 a are formed at one end of the part 1 a, while a second protrusion 5 b is formed at other end. Further, at one end of the part 1 b, a third protrusion 5 c to be fitted into the first recess 10 a, and a second recess 10 b positioned at the root of the third protrusion 5 c are formed, while a third recess 10 c to be fitted with the second protrusion 5 b is formed at other end.
  • The [0066] ring 1 of the embodiment is inserted into the capsule (see FIG. 6), first in a state of fitting the first protrusion 5 a into the second recess 10 b by means of jig such as forcept. When the third protrusion 5 c is fitted into the first recess 10 a, a tension is applied to the ring 1. In this state, when the sitting position in the capsule is determined, the second protrusion 5 b is fitted into the third recess 10 c. The material of the ring 1 of this embodiment is same as that of the ring of embodiment 1. Also the case of the ring of this embodiment, after fitting the first protrusion 5 a into the second recess 10 b, fitting the third protrusion 5 c into the first recess 10 a, and fitting the second protrusion 5 b into the third recess 10 c, when the ring diameter is contracted by 2 mm, a compressive load of about 250 mgf or more is obtained.
  • The ring of the invention is a so-called open ring with one or two or more cut sections. In the foregoing embodiments, the engaging or joining mechanism of cut sections is explained by referring to the drawings, but it is not limited to the illustrated engaging and joining mechanisms. [0067]
  • Incidentally, by using therapeutics, including ocular hypotensor such as distigmine bromide, carteolol chloride or timolol maleate, cataract remedy such as pyrenoxin or glutathione, ocular infection remedy such as aciclovir, idoxuridine, oxytetracycline hydrochloride, ofloxacin, sulbenicillin sodium, cefmenoxime hydrochloride, tobramycin, micronomycin hydrosulfate or pimaricin, or anti-inflammatory agents such as dexamethasone sodium phosphate, fluorometholone, metamethasone sodium phosphate, indomethacin or pranoprofen, antifungal agent such as griseofulvin, antibacterial agent such as gentamycin sulfate, antiviral agent such as vidarabine, aciclovir or didanosine, and diagnostic agent such as fluorescein sodium, when the surface of the ring (the contact surface of the ring and the lenticular capsule) of the invention is coated, or when mixed in the material of the ring, and it worn in the capsule, a sustained-release effect of the drug is obtained. [0068]
  • EMBODIMENT 5
  • As shown in FIGS. 24, 25 and [0069] 26, the ring 1 of EMBODIMENT 5 is characterized in that a flange portion FL is located in a position where both ends of the ring 1 are abutted to each other.
  • As the shape of the flange FL, not only the shape shown in FIGS. to [0070] 26, but also the shape shown in FIGS. 27(a) to 27(e), 28(a) to 28(d), 29(a) to 29(c) and 30(a) to 30(c) can be employed.
  • According to the present invention, since it is an intraocular ring of open ring shape when inserting, it can be inserted from a small incision, and after being inserted into the capsule, by engaging the engaging mechanisms having mutually complementary male and female structures provided at ends of the intraocular ring, the intraocular ring having a nearly same compressive load as in closed ring is obtained. [0071]

Claims (10)

What is claimed is:
1. An intraocular ring made of an elastic material, contacting with entire inner circumference of an equatorial area of a capsule after being inserted in the lenticular capsule, in which engaging mechanisms are provided at both ends, in a partially cut-off state of the intraocular ring, and a continuous ring shape without cut section is formed by engagement of the engaging mechanisms.
2. The intraocular ring of
claim 1
, wherein the ring engaging mechanisms include mutually complementary male and female structures.
3. An intraocular ring which is partially cut-off intraocular ring made of an elastic material, contacting with entire inner circumference of an equatorial area of a lenticular capsule after being inserted in the lenticular capsule, in which a continuous shape is formed when an intraocular ring is inserted in the lenticular capsule as both ends of the cut-off intraocular ring contact with each other.
4. The intraocular ring of
claim 3
, wherein the both ends of the intraocular ring are formed in a taper.
5. An intraocular ring comprising two or three or more parts made of an elastic material, and said intraocular ring contacting with entire inner circumference of an equatorial area of a lenticular capsule after being inserted in the lenticular capsule, in which the two or three or more parts individually have engaging mechanisms provided at both ends so that arbitrary adjacent parts may be engaged with each other in male-female structure, and a continuous ring shape without cut section is formed when the two or three or more parts are mutually engaged with each other.
6. The intraocular ring of
claim 1
or
claim 5
, wherein a predetermined compressive load is applied in an engaged state of the cut sections of the ring.
7. The intraocular ring of
claim 6
, wherein the compressive load is about 250 mgf or more.
8. The intraocular ring of
claim 3
, wherein a predetermined compressive load is applied in an abutted state of the cut section of the ring.
9. The intraocular ring of
claim 8
, wherein the compressive load is about 250 mgf or more.
10. The intraocular ring of
claim 3
, wherein at least one of both ends of the intraocular ring is provided with a flange.
US09/227,971 1998-01-12 1999-01-11 Intraocular ring Expired - Fee Related US6428572B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP4202/1998 1998-01-12
JP10-004202 1998-01-12
JP420298 1998-01-12
JP10-362568 1998-12-21
JP36256898 1998-12-21

Publications (2)

Publication Number Publication Date
US20010004708A1 true US20010004708A1 (en) 2001-06-21
US6428572B2 US6428572B2 (en) 2002-08-06

Family

ID=26337933

Family Applications (1)

Application Number Title Priority Date Filing Date
US09/227,971 Expired - Fee Related US6428572B2 (en) 1998-01-12 1999-01-11 Intraocular ring

Country Status (1)

Country Link
US (1) US6428572B2 (en)

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6413277B1 (en) * 2000-05-18 2002-07-02 Tobias H. Neuhann Method for intraocular lens insertion and apparatus
WO2003022182A1 (en) 2001-09-06 2003-03-20 Paul Rolf Preussner Rigidifiable capsule tensioning ring
US20030149479A1 (en) * 2002-01-18 2003-08-07 Snyder Michael E. Endocapsular tension ring sustained release device and method of making and using the same
US20040122174A1 (en) * 2002-10-11 2004-06-24 Mather Patrick T. Blends of amorphous and semicrystalline polymers having shape memory properties
US20060235515A1 (en) * 2003-01-08 2006-10-19 Christophe Chassain Capsular tension ring, method for making a capsular tension ring and capsular ring and intraocular lens assembly
US20070083260A1 (en) * 2005-10-07 2007-04-12 Michael Colvard Intraocular lens spacer for cataract surgery
WO2007044604A1 (en) * 2005-10-07 2007-04-19 Colvard D Michael Intraocular lens spacer for cataract surgery
WO2007104068A1 (en) * 2006-03-16 2007-09-20 Albert Daxer Cornea implant
US20070265599A1 (en) * 2006-05-12 2007-11-15 David Castillejos Optic nerve head implant and medication delivery system
EP1981436A1 (en) * 2006-01-17 2008-10-22 Minas Theodore Coroneo A capsular implant for maintaining the shape and/or position of an opening formed by capsulorhexis
US20090240327A1 (en) * 2006-05-23 2009-09-24 Albert Daxer Corneal Implant and Method for Correction of Impaired Vision in the Human Eye
US20110054600A1 (en) * 2009-06-26 2011-03-03 Abbott Medical Optics Inc. Accommodating intraocular lenses
US20110098790A1 (en) * 2009-10-26 2011-04-28 Albert Daxer Methods for treating corneal disease
US8404269B2 (en) 2003-04-11 2013-03-26 Michael Snyder Sustained release implantable eye device
US9039760B2 (en) 2006-12-29 2015-05-26 Abbott Medical Optics Inc. Pre-stressed haptic for accommodating intraocular lens
CN104812341A (en) * 2012-10-19 2015-07-29 加图立大学校产学协力团 Anterior capsulotomy guide device for cataract surgery
US9198752B2 (en) 2003-12-15 2015-12-01 Abbott Medical Optics Inc. Intraocular lens implant having posterior bendable optic
CN105326603A (en) * 2014-06-24 2016-02-17 爱博诺德(北京)医疗科技有限公司 Balloon tension ring
US9271830B2 (en) 2002-12-05 2016-03-01 Abbott Medical Optics Inc. Accommodating intraocular lens and method of manufacture thereof
US9504560B2 (en) 2002-01-14 2016-11-29 Abbott Medical Optics Inc. Accommodating intraocular lens with outer support structure
US9603703B2 (en) 2009-08-03 2017-03-28 Abbott Medical Optics Inc. Intraocular lens and methods for providing accommodative vision
US9636213B2 (en) 2005-09-30 2017-05-02 Abbott Medical Optics Inc. Deformable intraocular lenses and lens systems
US9814570B2 (en) 1999-04-30 2017-11-14 Abbott Medical Optics Inc. Ophthalmic lens combinations
US9968441B2 (en) 2008-03-28 2018-05-15 Johnson & Johnson Surgical Vision, Inc. Intraocular lens having a haptic that includes a cap
US9987125B2 (en) 2012-05-02 2018-06-05 Johnson & Johnson Surgical Vision, Inc. Intraocular lens with shape changing capability to provide enhanced accomodation and visual acuity
EP3269327A4 (en) * 2016-01-05 2018-10-31 Roberto Gustavo Albertazzi Arrangement of intrastromal segments
US11707354B2 (en) 2017-09-11 2023-07-25 Amo Groningen B.V. Methods and apparatuses to increase intraocular lenses positional stability

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6626941B2 (en) * 1998-12-23 2003-09-30 Anamed, Inc. Corneal implant and method of manufacture
US8668735B2 (en) 2000-09-12 2014-03-11 Revision Optics, Inc. Corneal implant storage and delivery devices
JP2004526467A (en) 2000-09-12 2004-09-02 アナメッド インク. Systems and methods for packaging and handling implants
WO2003020190A2 (en) * 2001-08-31 2003-03-13 Duckworth & Kent Limited Ophthalmic devices and procedures
AU2003284201A1 (en) * 2002-10-30 2004-06-07 Jaime. Zacharias Improved endocapsular tension ring and method of implanting same
US20060167422A1 (en) * 2003-12-30 2006-07-27 Mohsen Shahinpoor Heat Shrink Scleral Band With Custom-Made Buckle For Retinal Detachment Surgery
IL161706A0 (en) * 2004-04-29 2004-09-27 Nulens Ltd Intraocular lens fixation device
US10835371B2 (en) 2004-04-30 2020-11-17 Rvo 2.0, Inc. Small diameter corneal inlay methods
US7776086B2 (en) 2004-04-30 2010-08-17 Revision Optics, Inc. Aspherical corneal implant
US8057541B2 (en) 2006-02-24 2011-11-15 Revision Optics, Inc. Method of using small diameter intracorneal inlays to treat visual impairment
US10555805B2 (en) 2006-02-24 2020-02-11 Rvo 2.0, Inc. Anterior corneal shapes and methods of providing the shapes
US9271828B2 (en) 2007-03-28 2016-03-01 Revision Optics, Inc. Corneal implant retaining devices and methods of use
US8162953B2 (en) 2007-03-28 2012-04-24 Revision Optics, Inc. Insertion system for corneal implants
US9549848B2 (en) 2007-03-28 2017-01-24 Revision Optics, Inc. Corneal implant inserters and methods of use
US9539143B2 (en) 2008-04-04 2017-01-10 Revision Optics, Inc. Methods of correcting vision
WO2009124268A2 (en) 2008-04-04 2009-10-08 Revision Optics, Inc. Corneal inlay design and methods of correcting vision
US8647384B2 (en) * 2009-11-17 2014-02-11 Kenneth L. Lu Accommodating intraocular lens
US8469948B2 (en) 2010-08-23 2013-06-25 Revision Optics, Inc. Methods and devices for forming corneal channels
WO2013059813A1 (en) 2011-10-21 2013-04-25 Revision Optics, Inc. Corneal implant storage and delivery devices
WO2016144404A1 (en) 2015-03-12 2016-09-15 Revision Optics, Inc. Methods of correcting vision
EP3277220A4 (en) 2015-04-03 2018-12-19 The Regents of the University of Colorado, a body corporate Devices and methods for stabilization of an ocular lens capsule and preventing artificial intraocular lens implant rotation post cataract surgery

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4969897A (en) * 1984-09-12 1990-11-13 Kalb Irvin M Intraocular lens with retractable leg
US4666444A (en) * 1985-09-13 1987-05-19 Pannu Jaswant S Easily insertable intraocular lens
US5300118A (en) * 1992-09-21 1994-04-05 Keravision Adjustable devices for corneal curvature adjustment
US5323788A (en) * 1992-09-21 1994-06-28 Keravision Overlapping split ring device for corneal curvature adjustment
CA2168347A1 (en) * 1993-08-02 1995-02-09 Thomas A. Silvestrini Segmented preformed intrastromal corneal insert
US5522887A (en) * 1995-02-24 1996-06-04 Hoe; Michael J. V. Eye implant device and method
US5855604A (en) * 1996-12-09 1999-01-05 Microoptix, Llc Method and apparatus for adjusting corneal curvature using a solid filled corneal ring
US5733334A (en) * 1996-12-09 1998-03-31 Microoptix Method and apparatus for adjusting corneal curvature

Cited By (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9814570B2 (en) 1999-04-30 2017-11-14 Abbott Medical Optics Inc. Ophthalmic lens combinations
US6413277B1 (en) * 2000-05-18 2002-07-02 Tobias H. Neuhann Method for intraocular lens insertion and apparatus
WO2003022182A1 (en) 2001-09-06 2003-03-20 Paul Rolf Preussner Rigidifiable capsule tensioning ring
US9504560B2 (en) 2002-01-14 2016-11-29 Abbott Medical Optics Inc. Accommodating intraocular lens with outer support structure
US20030149479A1 (en) * 2002-01-18 2003-08-07 Snyder Michael E. Endocapsular tension ring sustained release device and method of making and using the same
US7090888B2 (en) * 2002-01-18 2006-08-15 Snyder Michael E Sustained release ophthalmological device and method of making and using the same
US20060246112A1 (en) * 2002-01-18 2006-11-02 Snyder Michael E Sustained release ophthalmological device and method of making and using the same
US20070135578A1 (en) * 2002-10-11 2007-06-14 Mather Patrick T Blends of amorphous and semicrystalline polymers having shape memory properties
US20040122174A1 (en) * 2002-10-11 2004-06-24 Mather Patrick T. Blends of amorphous and semicrystalline polymers having shape memory properties
US7208550B2 (en) * 2002-10-11 2007-04-24 The University Of Connecticut Blends of amorphous and semicrystalline polymers having shape memory properties
US7371799B2 (en) 2002-10-11 2008-05-13 University Of Connecticut Blends of amorphous and semicrystalline polymers having shape memory properties
US7795350B2 (en) 2002-10-11 2010-09-14 Connecticut, University Of Blends of amorphous and semicrystalline polymers having shape memory properties
US10206773B2 (en) 2002-12-05 2019-02-19 Johnson & Johnson Surgical Vision, Inc. Accommodating intraocular lens and method of manufacture thereof
US9271830B2 (en) 2002-12-05 2016-03-01 Abbott Medical Optics Inc. Accommodating intraocular lens and method of manufacture thereof
US20060235515A1 (en) * 2003-01-08 2006-10-19 Christophe Chassain Capsular tension ring, method for making a capsular tension ring and capsular ring and intraocular lens assembly
US8404269B2 (en) 2003-04-11 2013-03-26 Michael Snyder Sustained release implantable eye device
US9198752B2 (en) 2003-12-15 2015-12-01 Abbott Medical Optics Inc. Intraocular lens implant having posterior bendable optic
US9636213B2 (en) 2005-09-30 2017-05-02 Abbott Medical Optics Inc. Deformable intraocular lenses and lens systems
US20070083260A1 (en) * 2005-10-07 2007-04-12 Michael Colvard Intraocular lens spacer for cataract surgery
WO2007044604A1 (en) * 2005-10-07 2007-04-19 Colvard D Michael Intraocular lens spacer for cataract surgery
US9622857B2 (en) 2006-01-17 2017-04-18 Minas Theodore Coroneo Method of maintaining the structure of an opening in the anterior or posterior capsule
EP1981436A1 (en) * 2006-01-17 2008-10-22 Minas Theodore Coroneo A capsular implant for maintaining the shape and/or position of an opening formed by capsulorhexis
EP1981436A4 (en) * 2006-01-17 2013-03-06 Minas Theodore Coroneo A capsular implant for maintaining the shape and/or position of an opening formed by capsulorhexis
WO2007104068A1 (en) * 2006-03-16 2007-09-20 Albert Daxer Cornea implant
US8092526B2 (en) 2006-03-16 2012-01-10 Albert Daxer Cornea implant
US8377121B2 (en) 2006-03-16 2013-02-19 Albert Daxer Cornea implant
US20090076601A1 (en) * 2006-03-16 2009-03-19 Albert Daxer Cornea Implant
US20070265599A1 (en) * 2006-05-12 2007-11-15 David Castillejos Optic nerve head implant and medication delivery system
US7981096B2 (en) * 2006-05-12 2011-07-19 David Castillejos Optic nerve head implant and medication delivery system
US9510938B2 (en) 2006-05-23 2016-12-06 Albert Daxer Corneal implant and method for correction of impaired vision in the human eye
US20090240327A1 (en) * 2006-05-23 2009-09-24 Albert Daxer Corneal Implant and Method for Correction of Impaired Vision in the Human Eye
US9039760B2 (en) 2006-12-29 2015-05-26 Abbott Medical Optics Inc. Pre-stressed haptic for accommodating intraocular lens
US9968441B2 (en) 2008-03-28 2018-05-15 Johnson & Johnson Surgical Vision, Inc. Intraocular lens having a haptic that includes a cap
US9011532B2 (en) 2009-06-26 2015-04-21 Abbott Medical Optics Inc. Accommodating intraocular lenses
US10052194B2 (en) 2009-06-26 2018-08-21 Johnson & Johnson Surgical Vision, Inc. Accommodating intraocular lenses
US20110054600A1 (en) * 2009-06-26 2011-03-03 Abbott Medical Optics Inc. Accommodating intraocular lenses
US8486142B2 (en) 2009-06-26 2013-07-16 Abbott Medical Optics Inc. Accommodating intraocular lenses
WO2010151691A3 (en) * 2009-06-26 2011-03-10 Abbott Medical Optics Inc. Accommodating intraocular lenses
US9603703B2 (en) 2009-08-03 2017-03-28 Abbott Medical Optics Inc. Intraocular lens and methods for providing accommodative vision
US10105215B2 (en) 2009-08-03 2018-10-23 Johnson & Johnson Surgical Vision, Inc. Intraocular lens and methods for providing accommodative vision
US20110098790A1 (en) * 2009-10-26 2011-04-28 Albert Daxer Methods for treating corneal disease
US9987125B2 (en) 2012-05-02 2018-06-05 Johnson & Johnson Surgical Vision, Inc. Intraocular lens with shape changing capability to provide enhanced accomodation and visual acuity
US10004637B2 (en) 2012-10-19 2018-06-26 Catholic University Industry Academic Cooperation Foundation Anterior capsulotomy guide device for cataract surgery
CN104812341A (en) * 2012-10-19 2015-07-29 加图立大学校产学协力团 Anterior capsulotomy guide device for cataract surgery
CN105326603A (en) * 2014-06-24 2016-02-17 爱博诺德(北京)医疗科技有限公司 Balloon tension ring
EP3269327A4 (en) * 2016-01-05 2018-10-31 Roberto Gustavo Albertazzi Arrangement of intrastromal segments
US11707354B2 (en) 2017-09-11 2023-07-25 Amo Groningen B.V. Methods and apparatuses to increase intraocular lenses positional stability

Also Published As

Publication number Publication date
US6428572B2 (en) 2002-08-06

Similar Documents

Publication Publication Date Title
US6428572B2 (en) Intraocular ring
CN100404003C (en) Intraocular lens
US5628795A (en) Spare parts for use in ophthalmic surgical procedures
US9943404B2 (en) Intraocular cell migration inhibition system
CN100518691C (en) Method of Manufacturing capsular tension ring and capsular ring
EP0812166B1 (en) Accommodating intraocular lens having t-shaped haptics
EP0105929B1 (en) Posterior chamber lens implant
US8551167B2 (en) Intraocular implant cell migration inhibition system
CA1237556A (en) Fixation system for intraocularlens structures
US5776191A (en) Fixation system for intraocular lens structures
US4872876A (en) Universal fit intraocular lens
US8556967B2 (en) Interior bag for a capsular bag and injector
JP2001502592A (en) Intraocular implant
JP2000504612A (en) Intraocular implant for myopia correction
GB2180757A (en) Intraocular lens structure with polyimide haptic portion and methods for fabrication
WO1996029956A1 (en) Intraocular lens implant and tool for implanting
US20030220652A1 (en) Intraocular ring
JPH0323857A (en) Intraocular lens
CA3071496A1 (en) Intraocular lens
JP2000237218A (en) Intraocular ring

Legal Events

Date Code Title Description
AS Assignment

Owner name: MENICON CO., LTD., JAPAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NAGAI, HIDENOBU;REEL/FRAME:009706/0953

Effective date: 19981218

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20060806